Maria Duarte to Antibodies, Protozoan
This is a "connection" page, showing publications Maria Duarte has written about Antibodies, Protozoan.
Connection Strength
0.388
-
Ramos FF, Costa LE, Dias DS, Santos TTO, Rodrigues MR, Lage DP, Salles BCS, Martins VT, Ribeiro PAF, Ch?vez-Fumagalli MA, Dias ACS, Alves PT, Vieira ?LM, Roatt BM, Menezes-Souza D, Duarte MC, Teixeira AL, Goulart LR, Coelho EAF. Selection strategy of phage-displayed immunogens based on an in vitro evaluation of the Th1 response of PBMCs and their potential use as a vaccine against Leishmania infantum infection. Parasit Vectors. 2017 12 21; 10(1):617.
Score: 0.134
-
Oliveira-da-Silva JA, Machado AS, Ramos FF, Tavares GSV, Lage DP, Mendon?a DVC, Pereira IAG, Santos TTO, Martins VT, Carvalho LM, Freitas CS, Ludolf F, Reis TAR, Bandeira RS, Silva AM, Costa LE, Oliveira JS, Duarte MC, Roatt BM, Teixeira AL, Coelho EAF. A Leishmania amastigote-specific hypothetical protein evaluated as recombinant protein plus Th1 adjuvant or DNA plasmid-based vaccine to protect against visceral leishmaniasis. Cell Immunol. 2020 10; 356:104194.
Score: 0.040
-
Oliveira-da-Silva JA, Lage DP, Ramos FF, Machado AS, Tavares GSV, Mendon?a DVC, Pereira IAG, Martins VT, Carvalho LM, Ludolf F, Santos TTO, Reis TAR, Oliveira CS, Bandeira RS, Silva AM, Costa LE, Oliveira JS, Duarte MC, Menezes-Souza D, Roatt BM, Teixeira AL, Coelho EAF. Leishmania infantum pyridoxal kinase evaluated in a recombinant protein and DNA vaccine to protects against visceral leishmaniasis. Mol Immunol. 2020 08; 124:161-171.
Score: 0.040
-
Lage DP, Machado AS, Ramos FF, Silveira PC, Dias DS, Ribeiro PAF, Tavares GSV, Costa LE, Santos TTO, Steiner BT, Fagundes MI, Ch?vez-Fumagalli MA, Lyon S, Moreira RLF, Duarte MC, Menezes-Souza D, Caligiorne RB, Machado-de-?vila RA, Teixeira AL, Coelho EAF. A biomarker for tegumentary and visceral leishmaniasis based on a recombinant Leishmania hypothetical protein. Immunobiology. 2019 07; 224(4):477-484.
Score: 0.037
-
Ribeiro PAF, Dias DS, Lage DP, Martins VT, Costa LE, Santos TTO, Ramos FF, Tavares GSV, Mendon?a DVC, Ludolf F, Gomes DA, Rodrigues MA, Ch?vez-Fumagalli MA, Silva ES, Galdino AS, Duarte MC, Roatt BM, Menezes-Souza D, Teixeira AL, Coelho EAF. Immunogenicity and protective efficacy of a new Leishmania hypothetical protein applied as a DNA vaccine or in a recombinant form against Leishmania infantum infection. Mol Immunol. 2019 02; 106:108-118.
Score: 0.036
-
Ribeiro PAF, Dias DS, Lage DP, Costa LE, Martins VT, Tavares GSV, Mendon?a DVC, Lima MP, Oliveira JS, Steiner BT, Machado-de-?vila RA, Roatt BM, Ch?vez-Fumagalli MA, Menezes-Souza D, Duarte MC, Teixeira AL, Coelho EAF. Evaluation of a Leishmania hypothetical protein administered as DNA vaccine or recombinant protein against Leishmania infantum infection and its immunogenicity in humans. Cell Immunol. 2018 09; 331:67-77.
Score: 0.034
-
Dias DS, Ribeiro PAF, Martins VT, Lage DP, Costa LE, Ch?vez-Fumagalli MA, Ramos FF, Santos TTO, Ludolf F, Oliveira JS, Mendes TAO, Silva ES, Galdino AS, Duarte MC, Roatt BM, Menezes-Souza D, Teixeira AL, Coelho EAF. Vaccination with a CD4+ and CD8+ T-cell epitopes-based recombinant chimeric protein derived from Leishmania infantum proteins confers protective immunity against visceral leishmaniasis. Transl Res. 2018 10; 200:18-34.
Score: 0.034
-
Dias DS, Ribeiro PAF, Martins VT, Lage DP, Portela ?SB, Costa LE, Salles BCS, Lima MP, Ramos FF, Santos TTO, Caligiorne RB, Ch?vez-Fumagalli MA, Silveira JAG, Magalh?es-Soares DF, Gon?alves DU, Oliveira JS, Roatt BM, Duarte MC, Menezes-Souza D, Silva ES, Galdino AS, Machado-de-?vila RA, Teixeira AL, Coelho EAF. Recombinant small glutamine-rich tetratricopeptide repeat-containing protein of Leishmania infantum: Potential vaccine and diagnostic application against visceral leishmaniasis. Mol Immunol. 2017 11; 91:272-281.
Score: 0.033